Slovenia resumes use of AstraZeneca vaccine after brief suspension
Ljubljana, 18 March - Slovenia has decided to resume using the AstraZeneca vaccine after the European Medicines Agency (EMA) assessed AstraZeneca's Covid-19 vaccine "safe and effective" after a review of possible blood clot risks.
Ljubljana
Health Ministrer Janez Poklukar.
Photo: Anže Malovrh/STA
The rest of this news item is available to subscribers.
The news item consists of 758 characters (without spaces) or 139 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.